Back to top

Analyst Blog

On Sep 24, Zacks Investment Research upgraded Lincoln National Corporation (LNC - Analyst Report) to a Zacks Rank #1 (Strong Buy).

Why the Upgrade?

Lincoln National has been witnessing rising earnings estimates on the back of strong second-quarter 2013 results. Moreover, this insurance and investment manager delivered positive earnings surprises in 3 out of the last 4 quarters with an average beat of 5.9%. Shares gained nearly 0.5% since the company reported solid second quarter results.

Lincoln National’s second quarter operating earnings per share came in at $1.27, surpassing the Zacks Consensus Estimate of $1.15 and year ago earnings by 16.5%. The outperformance was driven by improved sales of insurance policies, variable annuities as well as non-medical net earned premiums.

Additionally, Lincoln Financial has undertaken a number of initiatives over the last couple of months that are expected to be potent to its growth in the upcoming period. The introduction of an e-ticket system and e-delivery for its hybrid life insurance policies on Aug 6, 2013 not only marks the expansion of Lincoln National’s electronic business, but also strengthens its life insurance portfolio. The e-business of Lincoln National also has been fortified by the launch of iPipeline iGO e-App that allows professionals to complete and submit insurance applications electronically. On Aug 13, 2013, it launched a variable universal life insurance product named Lincoln SVUL that we believe will enhance its competitive position in the life insurance market.

Moreover, the strengthening of the company’s Ibbotson Insight Series through the launch of a number of new lineups and the introduction of the company’s first ever deferred income annuity (DIA) named Lincoln Deferred Income Solutions in Sep 2013 is expected to bolster top line growth. Its clientele base is also expected to increase on account of its deal with the blood center, OneBlood on Aug 8, 2013, whereby it will provide employer sponsored retirement plans to OneBlood employees.   

The Zacks Consensus Estimate for 2013 increased 5.1% to $4.73 per share as 15 of 17 estimates were revised higher over the last 60 days. The Zacks Consensus Estimate for 2014 also increased approximately 5.1% to $5.20 as 13 of 17 estimates moved north over the last 60 days.

Other Stocks to Consider

Among other insurers, China Life Insurance Co. Ltd. (LFC - Analyst Report), StanCorp Financial Group Inc. (SFG - Analyst Report) and Torchmark Corporation (TMK - Analyst Report) carry a Zacks Rank #2 (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
PLANAR SYST… PLNR 4.44 +5.21%
BITAUTO HOL… BITA 81.71 +5.12%
CTPARTNERS… CTP 16.66 +4.26%
CHINA BIOLO… CBPO 47.91 +3.30%
MALLINCKROD… MNK 72.94 +2.85%